Bepridil enhances in vitro antitumor activity of antiestrogens in human brain tumor cells

Cancer Letters

Volumn 110, Issue 1-2, 1996, Pages 243-248

  Lee, Yong Soo ^a   Wurster, Robert D ^b  

^a Catholic Kwandong University   (South Korea)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiestrogens; Bepridil; Human brain tumors; Intracellular Ca2+; Na+ Ca2+ exchange

Indexed keywords

ANTIESTROGEN; BENZAMIL; BEPRIDIL; CALCIUM CHELATING AGENT; CALCIUM ION; CLOMIFENE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; NAFOXIDINE; NICKEL; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SODIUM CALCIUM EXCHANGE;

BEPRIDIL; BRAIN NEOPLASMS; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; CLOMIPHENE; DRUG SYNERGISM; ESTROGEN ANTAGONISTS; HUMANS; NAFOXIDINE; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0030596042     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04518-1     Document Type: Article

References (20)

1. [1] Schanne, F., Kane, A.B., Young, E.E. and Farber, J.L. (1979) Calcium dependence of toxic cell death, Science, 206, 700-702.
2. 2+-ATPase inhibitor thapsigargin, Exp. Cell Res., 212, 84-92.
3. 2+ fluxes, Proc. Natl. Acad. Sci. USA, 91, 6569-6573.
4. [4] Lee, Y.S. and Wurster, R.D. (1994) Dual effects of estrogen and antiestrogens on the growth of SK-N-MC human neuroblastoma cells, Cancer Lett., 86, 119-125.
5. [5] Kleyman, T.R. and Cragoe Jr, E.J. (1988) Amiloride and its analogs as tools in the study of ion transport, J. Membr. Biol., 105, 1-21.
6. 2+ exchange blockers on the growth of human brain tumor cells, Cancer Lett., 86, 224-228.
7. 2+ in T cells, Cell. Immunol., 147, 95-109.
8. 2+ exchanger, J. Neurosci., 12, 430-439.
9. [9] Kaczorowski, G.J., Slaughter, R.S., Garcia, M.L. and King, V.F. (1988) Block of cardiac sodium-calcium exchange by mechanism-based inhibitors, Progr. Clin. Biol. Res., 252, 261-266.
10. [10] Gill, A., Flaim, S.F., Damiano, B.P., Sit, S.P. and Brannan, M.D.(1992) Pharmacology of bepridil. Am. J. Cardiol., 69, 11D-16D.
11. 2+ exchange in human neutrophils, Am. J. Physiol., 254, C150-C164.
12. 2+-exchange current in cardiac myocytes: mediation by sulfhydryl groups?, Am. J. Physiol., 266, H909-H919.
13. 2+ in IL 3-induced potentiation of IgE-mediated histamine release from human basophils, Clin. Exp. Immunol., 95, 191-194.
14. [14] Kiwit, J.C.W., Hertel, A. and Matuschek, A.E. (1994) Reversal of chemoresistance in malignant gliomas by calcium channel antagonists: correlation with the expression of multi-drug-resistant p-glycoprotein, J. Neurosurg., 81, 587-594.
15. [15] Baeyens, J.M. (1988) Interactions between calcium channel blockers and non-cardiovascular drugs: interactions with anticancer drugs, Pharmacol. Toxicol., 63, 1-7.
16. [16] Ozols, R.F., Cunnion, R.E., Klecker Jr, R.W., Hamilton, T.C., Ostcheoa, Y., Parrillo, J.E. and Young, R.C. (1987) Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients, J. Clin. Oncol., 5, 641-647.
17. [17] Dalton, W.S., Grogan, T.M., Meltzer, P.S., Scheper, R.J., Durie, B.G., Taylor, C.W., Miller, T.P. and Salmon, S.E. (1989) Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of p-glycoprotein and potential circumvention by the addition of verapamil to chemotherapy, J. Clin. Oncol., 7, 415-424.
18. [18] Schuurhuis, G.J., Pinedo, H.M., Broxterman, H.J., van Kalken, C.K., Kuiper, C.M. and Lankelma, J. (1990) Differential sensitivity of multi-drug-resistant and -sensitive cells to resistance-modifying agents and the reaction with reversal of anthracycline resistance, Int. J. Cancer, 46, 330-336.
19. [19] Schuurhuis, G.J., Broxterman, H.J., van der Hoeven, J.J.M., Pinedo, H.M. and Lankelma, J. (1987) Potentiation of doxorubicin cytotoxicity by the calcium channel antagonist bepridil in anthracycline-resistant and -sensitive cell lines, A comparison with verapamil. Cancer Chemother. Pharmacol., 20, 285-290.
20. [20] van Kalken, C.K., van der Hoeven, J.J.M., de Jong, J., Giaccone, G., Schuurhuis, G.J., Maessen, P.A., Blokhuis, W.M., van der Vijgh, W.J. and Pinedo, H.M. (1991) Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients, Eur. J. Cancer, 27, 739-744.